ID   CWR22Pc
AC   CVCL_LI38
DR   cancercelllines; CVCL_LI38
DR   Wikidata; Q54817055
RX   PubMed=18829484;
RX   PubMed=21248069;
RX   PubMed=27271795;
CC   Population: Caucasian.
CC   Characteristics: Androgen-dependent. Expresses full-length AR and PSA.
CC   Sequence variation: Mutation; HGNC; 644; AR; Simple; p.His875Tyr (c.2623C>T); ClinVar=VCV000009834; Zygosity=Hemizygous (PubMed=18829484).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=27271795
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 13,14,15
ST   D5S818: 11,12
ST   D7S820: 9,10,11
ST   D8S1179: 13
ST   FGA: 20,23
ST   Penta D: 9,12
ST   Penta E: 5,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3967 ! CWR22
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 05-10-23; Version: 10
//
RX   PubMed=18829484; DOI=10.1158/1078-0432.CCR-08-0979;
RA   Dagvadorj A., Tan S.-H., Liao Z.-Y., Cavalli L.R., Haddad B.R.,
RA   Nevalainen M.T.;
RT   "Androgen-regulated and highly tumorigenic human prostate cancer cell
RT   line established from a transplantable primary CWR22 tumor.";
RL   Clin. Cancer Res. 14:6062-6072(2008).
//
RX   PubMed=21248069; DOI=10.1158/0008-5472.CAN-10-1998;
RA   Li Y.-M., Alsagabi M., Fan D.-H., Bova G.S., Tewfik A.H., Dehm S.M.;
RT   "Intragenic rearrangement and altered RNA splicing of the androgen
RT   receptor in a cell-based model of prostate cancer progression.";
RL   Cancer Res. 71:2108-2117(2011).
//
RX   PubMed=27271795; DOI=10.1002/pros.23190;
RA   Shourideh M., DePriest A., Mohler J.L., Wilson E.M., Koochekpour S.;
RT   "Characterization of fibroblast-free CWR-R1ca castration-recurrent
RT   prostate cancer cell line.";
RL   Prostate 76:1067-1077(2016).
//